Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Adams, M., Calvert, A. H., Carmichael, J., Clark, P. I., Coleman, R. E., Earl, H. M., Gallagher, C. J., Ganesan, T. S., Gore, M. E., Graham, J. D., Harper, P. G., Jayson, G. C., Kaye, S. B., Ledermann, J. A., Osborne, R. J., Perren, T. J., Poole, C. J., Radford, J. A., Rustin, G. J. S., Slevin, M. L., Smyth, J. F., Thomas, H. & Wilkinson, P. M. (1988). Chemotherapy for ovarian cancer – a consensus statement on standard practice. Br J Cancer 78: 1404–1406.
Calman & Hine (1995). A Policy Framework for Commissioning Cancer Services. Guidance for Purchasers and Providers of Cancer Services. Department of Health: London
Faught, W., Lotocki, R. J., Heywood, M. & Krepart, G. V. (1996). Early ovarian cancer. Value of a negative staging laparotomy. Eur J Gynaecol Oncol 17: 200–203.
Hawkins, R. E. (1988). Chemotherapy for ovarian cancer – trials, controversies and funding. Br J Cancer 78: 1402–1403.
Junor, E. J., Hole, D. J. & Gillis, C. R. (1994). Management of ovarian cancer. Referral to a multidisciplinary team matters. Br J Cancer 70: 363–370.
Mayer, A. R., Chambers, S. K., Graves, E., Holm, C., Tseng, P. C., Nelson, B. E. & Schwartz, P. E. (1992). Ovarian cancer staging: does it require a gynecologic oncologist?. Gynecol Oncol 47: 223–227.
Nguyen, H. N., Averette, H. E., Hoskins, W., Penalver, M., Sevin, B-U & Steren, A. (1993). National Survey of Ovarian Cancer Part V: The impact of physician’s speciality on patients’ survival. Cancer 72: 3663–3370.
Petru, E., Lahousen, M., Tamussino, K., Pickel, H., Stranzl, H., Stettner, H. & Winter, R. (1994). Lymphadenectomy in stage I ovarian cancer. Am J Obs Gynecol 170: 656–662.
Sandercock, J., Parmar, M. K. B. & Torri, V. (1998). First-line chemotherapy for advanced ovarian cancer: paclitaxel, cisplatin and the evidence. Br J Cancer 78: 1471–1478.
Schueler, J. A., Trimbos, J. B., Hermans, J. & Fleuren, G. J. (1998). The yield of surgical staging in presumed early stage ovarian cancer. Benefits or doubts? Int J Gynecol Cancer 8: 95–102.
Scott, J. S. (1991). Management of Ovarian Cancer. Current Clinical Practices. Report of a Working Group. Standing Subcommittee on Cancer of the Standing Medical Advisory Committee: London
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Chan, K. Does the surgeon matter in the management of ovarian cancer?. Br J Cancer 80, 1492–1493 (1999). https://doi.org/10.1038/sj.bjc.6690550
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690550